Bulent Ozpolat

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Staphylococcus Aureus

Breast Cancer Risk

Cell Proliferation

Top Venues

Journal of molecular medicine (Berlin, Germany)

ACS pharmacology & translational science

Breast cancer (Tokyo, Japan)

Molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Ahsen Guler, Zuhal Hamurcu, Halil Ulutabanca, Venhar Cınar, Nursultan Nurdinov, Serife Erdem, Bulent Ozpolat
Flavopiridol Suppresses Cell Proliferation and Migration and Induces Apoptotic Cell Death by Inhibiting Oncogenic FOXM1 Signaling in IDH Wild-Type and IDH-Mutant GBM Cells. Molecular neurobiology (2023)
Venhar Cınar, Bulent Ozpolat, Ahsen Guler, Nursultan Nurdinov, Bulent Ozpolat
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1. Breast cancer (Tokyo, Japan) 29 (6) (2022)
Ferah Comert Onder, Nermin Kahraman, Esen Bellur Atici, Ali Cagir, Hakan Kandemir, Gizem Tatar, Tugba Taskin Tok, Goknur Kara, Bekir Karliga, Serdar Durdagi, Mehmet Ay, Bulent Ozpolat
Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo". ACS pharmacology & translational science 4 (3) (2021)
Sevide Sencan, Mine Tanriover, Mustafa Ulasli, Didem Karakas, Bulent Ozpolat
UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-β/Src signaling in breast cancer cells. Molecular and cellular biochemistry 476 (5) (2021)
Didem Karakas, Bulent Ozpolat
Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. Journal of molecular medicine (Berlin, Germany) 98 (6) (2020)